MYOV stock: buy or sell?
July 15th, 2019
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health and endocrine diseases.
Should I buy MYOV stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, Myovant Sciences stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Myovant Sciences stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we detected 3 ratings published for MYOV stock in the last month.
|Date||Analyst / Broker||Previous rating||Current rating|
MYOV stock analysis
Shares of Myovant Sciences closed yesterday at $8.82 and soared a pretty good 2.68%.
Shares of Myovant Sciences soared a pretty good 2.68% and closed at $8.82. Since April when MYOV stock price broke down the SMA200d line, it slid $-13.06 per share (-59.69%).
Myovant Sciences ended this week at $8.82 and soared a fine 2.68%. By mid June MYOV collapsed a hair-raising -12.43% in just one week. By mid June MYOV climbed an astounding 6.66% in just one week.
Myovant Sciences is in a clear downtrend, marking consecutive declining peaks and bottoms. Now is trading in between the - range. If the support holds the price, this might mark a double bottom pattern and create a flat-base to reverse this downtrend. Since early April, when MYOV stock price broke down the 40-weeks moving avarage line, it slid $-15.62 per share (-63.91%). Trading stocks that are below the 40-weeks (that is, 200-days) moving average line is not recommended by many experts, as it indicates that the stock has not enough institutional support. Far behind is the all-time high Myovant Sciences recorded late September 2018 and since then the price is -67.87% below that top.
MYOV stock price history
MYOV stock went public on October 27th, 2016 with a price of $15.001. Since then, MYOV stock sliced a -41.20%, with a yearly average of -20.60%.
1: Adjusted price after possible price splits or reverse-splits.
MYOV stock historical price chart
MYOV stock reached all-time highs on September with a price of $27.45.
MYOV stock price target is $25.00Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last 30 days we found 3 price targets for MYOV stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
Financials and fundamental analysis
Earnings date and Earnings per ShareMyovant Sciences presented slightly good results for 2018-Q4 on February. Myovant Sciences appreciated Earnings per Share (EPS) by 5.10%, beating experts consensus of $-0.99. Myovant Sciences posted $-1.04.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to , last anual revenues report draw of to M USD. , its earnings margin (compared to sales) to , that is million.
Quarterly financial resultsReported quarter income marked $-70.63 million with a profit margin of . Profit margin remained steady a 0.00% compared to previous quarter when profit margin was inf%. When comparing revenues to same quarter last year, Myovant Sciences sales marked a tight move and stayed stable a nan%. Looking back to recent quarterly results, Myovant Sciences posted 7 negative quarters in a row.
Myovant Sciences ownershipWhen you are planning to buy a stock, it's always worth to review its ownership structure.
Myovant Sciences shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 67.07% of all shares.
In case of Myovant Sciences stock, 31.04% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for MYOV stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Myovant Sciences:
|Market cap||$636.8 M|
|Total shares||72.2 M|
|Float shares||32.0 M|
|- Institutional holdings (%)||31.0%|
|- Insider holdings (%)||67.1%|
|Shares in short selling||0.0%|
|Monday, July 15th, 2019|
|Day range||$8.52 - $8.91|
|Average true range||$0.50|
|50d mov avg||$11.10|
|100d mov avg||$16.41|
|200d mov avg||$17.98|
Myovant Sciences performanceTo measure stock performance is always good to compare with competitors or related stocks. We selected as the bechmarking frame for Myovant Sciences stock.